SCHEMBL8522275

SCHEMBL8522275

CCCCCn1c(N)nc2nc[nH]c2c1=O

nearest known ligand 0.61

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ ADORA2B P29275 7/20 0.61
▸ PDE4A P27815 12/20 0.54
▸ PDE4B Q07343 12/20 0.54
▸ PDE4C Q08493 12/20 0.54
▸ PDE4D Q08499 12/20 0.54
▸ ADORA2A P29274 10/20 0.54
▸ ADORA3 P0DMS8 1/20 0.51
▸ CDK1 P06493 3/20 0.48
▸ CCNB1 P14635 3/20 0.48
▸ CCNA2 P20248 2/20 0.48
▸ CDK2 P24941 2/20 0.48
▸ CCNA1 P78396 2/20 0.48
▸ PIN1 Q13526 1/20 0.46
▸ XDH P47989 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6272301 0.99 ADORA2B (0.64) ADORA2BPDE4APDE4BPDE4CPDE4D
SCHEMBL4384741 0.99 ADORA2B (0.64) ADORA2BPDE4APDE4BPDE4CPDE4D
SCHEMBL8536009 0.99 ADORA2B (0.64) ADORA2BPDE4APDE4BPDE4CPDE4D
Hydrochloric Acid SCHEMBL258898 0.97 ADORA2B (0.62) ADORA2BPDE4APDE4BPDE4CPDE4D
SCHEMBL6272735 0.96 PDE4A (0.59) ADORA2BPDE4APDE4BPDE4CPDE4D
Acetic Acid SCHEMBL4280720 0.93 ADORA2B (0.57) ADORA2BPDE4APDE4BPDE4CPDE4D
SCHEMBL667797 0.90 PDE4A (0.60) ADORA2BPDE4APDE4BPDE4CPDE4D
SCHEMBL874737 0.84 ADORA2A (0.56) ADORA2BPDE4APDE4BPDE4CPDE4D
SCHEMBL28721443 0.83 CDK1 (0.53) ADORA2BPDE4APDE4BPDE4CPDE4D
SCHEMBL3671339 0.82 DPP4 (0.44) ADORA2BPDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116234585-A Microtubule-associated protein TAU (MAPT) iRNA agent compositions and methods of use thereof 阿尔尼拉姆医药品有限公司 2023-06-06 — — CN disclosed
CN-115298312-A Leucine-rich repeat kinase 2 (LRRK 2) iRNA agent compositions and methods of use thereof 阿尔尼拉姆医药品有限公司 2022-11-04 — — CN disclosed
CN-114796255-A Application of nicotinamide mononucleotide in protecting liver from being damaged 深圳市旷逸生物科技有限公司 2022-07-29 — — CN disclosed
CN-114728018-A Huntington (HTT) iRNA pharmaceutical compositions and methods of use thereof 阿尔尼拉姆医药品有限公司 2022-07-08 — — CN disclosed
CN-110218727-A For treating the exon skipping composition of muscular dystrophy 萨勒普塔医疗公司 2019-09-10 — — CN disclosed
CN-110066793-A For treating amyotrophic exon skipping composition 萨勒普塔医疗公司 2019-07-30 — — CN disclosed
CN-105378081-B Exon skipping compositions for the treatment of muscular dystrophy 萨勒普塔医疗公司 2019-06-14 — — CN disclosed
CN-105392884-B Exon skipping compositions for the treatment of muscle atrophy 萨勒普塔医疗公司 2018-11-30 — — CN disclosed
EP-0704445-B1 Preparation of N-9 substituted guanine compounds HOFFMANN LA ROCHE (CH) 1999-04-21 — — EP disclosed
US-5565565-A Preparation of N-9 substituted guanine compounds SYNTEX (U.S.A.) INC. (US) 1996-10-15 — — US disclosed
EP-0704445-A1 Preparation of N-9 substituted guanine compounds F. Hoffmann-La Roche AG (CH) 1996-04-03 — — EP disclosed
EP-0590361-A1 Process for the preparation of 2-amino-6-halopurines BASF Aktiengesellschaft (DE) 1994-04-06 — — EP disclosed
US-4914131-A HERPES SIMPLEX VIRUS; LIDOCAINE OR ITS SALTS Brigham, Dana P. (US) 1990-04-03 — — US disclosed
US-4757088-A Administering lidocaine and pantothenic acid; herpes Brigham, Dana P. (US) 1988-07-12 — — US disclosed
US-4628063-A LIDOCAINE, PANTOTHENOL, HERPES Brigham, Dana P. (US) 1986-12-09 — — US disclosed
Send feedback